Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

BUY
$0.22 - $0.4 $1,536 - $2,794
6,986 Added 69.71%
17,007 $4,000
Q2 2023

Jul 13, 2023

SELL
$0.35 - $0.6 $3 - $6
-11 Reduced 0.11%
10,021 $4,000
Q1 2023

May 11, 2023

BUY
$0.55 - $1.17 $5,517 - $11,737
10,032 New
10,032 $6,000
Q1 2021

May 07, 2021

SELL
$6.09 - $12.2 $66,837 - $133,895
-10,975 Closed
0 $0
Q4 2020

Feb 04, 2021

SELL
$3.56 - $10.21 $30,961 - $88,796
-8,697 Reduced 44.21%
10,975 $96,000
Q3 2020

Oct 29, 2020

BUY
$2.49 - $5.16 $12,811 - $26,548
5,145 Added 35.42%
19,672 $88,000
Q2 2020

Jul 27, 2020

SELL
$1.65 - $3.4 $6,941 - $14,303
-4,207 Reduced 22.46%
14,527 $46,000
Q1 2020

May 08, 2020

BUY
$1.52 - $2.66 $28,475 - $49,832
18,734 New
18,734 $30,000

Others Institutions Holding AQB

About AquaBounty Technologies, Inc.


  • Ticker AQB
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Farm Products
  • Shares Outstandng 71,110,704
  • Market Cap $84.6M
  • Description
  • AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sel...
More about AQB
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.